Patent · US Active

Bicyclic pyrimidine kinase inhibitors

US8314234B2 · kind B2 · utility

0Cited by

0References

7Claims

0Family size

Assignee

Janssen Pharmaceutica NA · BE

Inventors

Peter J. Connolly · New Providence, US
Stuart Emanuel · Doylestown, US
Ronghui Lin · Ambler, US
Yanhua Lu · Green Brook, US
Steven A. Middleton · Flemington, US

Key dates

Filing date	Sep 20, 2007
Grant date	Nov 20, 2012
Priority date	—
Expiry date	Jul 25, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D498/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to novel bicyclic pyrimidine compounds of Formula (I) or a form or composition thereofand the use thereof as inhibitors of ATP-protein kinase interactions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.